In this study, we examined the interaction process of human serum albumin (HSA) with a water-soluble zinc(II) complex of dichloro {2-[N-(2-hydroxyethylammonioethyl) imino methyl] phenol} at pH = 7.4 and in vitro utilizing molecular docking modeling and spectral techniques. In the multi-temperature fluorescence test, the consecutive and gradual addition of the zinc(II) complex to the HSA-containing cell resulted in fluorescence quenching, and it showed that the zinc(II) complex-protein interaction is associated with a static quenching mechanism; also, the number of binding sites (n) and the binding constant (K b ) were computed by this test. The evaluation of thermodynamic data showed spontaneous progression, and the involvement of hydrogen bonding/van der Waals forces in protein-zinc(II)complex formation. The site markers competition studies using two drugs, warfarin and ibuprofen, indicated that zinc(II) complex binds to the protein via site I/sub-domain IIA. The albumin-zinc(II) complex interaction and the structural alterations in the serum albumin were proved by electronic absorption technique and circular dichroism spectroscopy. Job's curve exhibited a stoichiometric ratio of 1 : 1 in the HSA-zinc(II) complex adduct. The accuracy of the results obtained from experimental findings on the interaction between HSA and zinc(II) complex was checked by molecular docking simulation, which illustrated a good agreement between experimental and theoretical data.